BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koneczny I. A New Classification System for IgG4 Autoantibodies. Front Immunol 2018;9:97. [PMID: 29483905 DOI: 10.3389/fimmu.2018.00097] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Hao M. Unique properties of IgG4 antibody and its clinical application in autoimmune pancreatitis. Scand J Gastroenterol 2018;53:1121-31. [PMID: 30175675 DOI: 10.1080/00365521.2018.1476915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ricken G, Schwaiger C, De Simoni D, Pichler V, Lang J, Glatter S, Macher S, Rommer PS, Scholze P, Kubista H, Koneczny I, Höftberger R. Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis. Front Neurol 2018;9:841. [PMID: 30364136 DOI: 10.3389/fneur.2018.00841] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
3 Yanovsky RL, McLeod M, Ahmed AR. Treatment of pemphigus vulgaris: part 2 - emerging therapies. Expert Rev Clin Immunol 2019;15:1061-71. [PMID: 31575295 DOI: 10.1080/1744666X.2020.1672539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Grüner J, Stengel H, Werner C, Appeltshauser L, Sommer C, Villmann C, Doppler K. Anti-contactin-1 Antibodies Affect Surface Expression and Sodium Currents in Dorsal Root Ganglia. Neurol Neuroimmunol Neuroinflamm 2021;8:e1056. [PMID: 34429341 DOI: 10.1212/NXI.0000000000001056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sinkovits G, Szilágyi Á, Farkas P, Inotai D, Szilvási A, Tordai A, Rázsó K, Réti M, Prohászka Z. Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura. Front Immunol 2018;9:1646. [PMID: 30061898 DOI: 10.3389/fimmu.2018.01646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Jarrell JA, Baker MC, Perugino CA, Liu H, Bloom MS, Maehara T, Wong HH, Lanz TV, Adamska JZ, Kongpachith S, Sokolove J, Stone JH, Pillai SS, Robinson WH. Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease. J Allergy Clin Immunol 2021:S0091-6749(21)00729-6. [PMID: 33974929 DOI: 10.1016/j.jaci.2021.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Young SG, Fong LG, Beigneux AP, Allan CM, He C, Jiang H, Nakajima K, Meiyappan M, Birrane G, Ploug M. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism. Cell Metab 2019;30:51-65. [PMID: 31269429 DOI: 10.1016/j.cmet.2019.05.023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
8 Takamori M. Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability. Front Mol Neurosci 2020;13:86. [PMID: 32547365 DOI: 10.3389/fnmol.2020.00086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Wang Z, Zhou X, Zhao N, Xie C, Zhu D, Guan Y. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations. Neurol Sci 2021;42:2223-33. [PMID: 33782779 DOI: 10.1007/s10072-021-05220-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Petit M, Walet-Balieu ML, Schapman D, Golinski ML, Burel C, Barray M, Drouot L, Maho-Vaillant M, Hébert V, Boyer O, Bardor M, Joly P, Calbo S. Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines 2021;9:1411. [PMID: 34680528 DOI: 10.3390/biomedicines9101411] [Reference Citation Analysis]
11 Gallo D, Piantanida E, Gallazzi M, Bartalena L, Tanda ML, Bruno A, Mortara L. Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher. Front Endocrinol (Lausanne) 2020;11:406. [PMID: 32765422 DOI: 10.3389/fendo.2020.00406] [Reference Citation Analysis]
12 Zografou C, Vakrakou AG, Stathopoulos P. Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders. Front Immunol 2021;12:686466. [PMID: 34220839 DOI: 10.3389/fimmu.2021.686466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Prüss H. Autoantibodies in neurological disease. Nat Rev Immunol 2021. [PMID: 33976421 DOI: 10.1038/s41577-021-00543-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen M, Zhao Q, Diao L, Xue K, Ruan Y, Xue F, Li J, Shi R, Pan M, Zheng J, Cao H. Distribution of anti-melanoma differentiation associated gene 5 (MDA5) IgG subclasses in MDA5+ dermatomyositis. Rheumatology (Oxford) 2021:keab268. [PMID: 33742662 DOI: 10.1093/rheumatology/keab268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 McQuiston A, Emtiazjoo A, Angel P, Machuca T, Christie J, Atkinson C. Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant. Front Immunol 2021;12:711102. [PMID: 34456920 DOI: 10.3389/fimmu.2021.711102] [Reference Citation Analysis]
16 van de Logt AE, Fresquet M, Wetzels JF, Brenchley P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 2019;96:1292-1302. [PMID: 31611068 DOI: 10.1016/j.kint.2019.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
17 Napodano C, Marino M, Stefanile A, Pocino K, Scatena R, Gulli F, Rapaccini GL, Delli Noci S, Capozio G, Rigante D, Basile U. Immunological Role of IgG Subclasses. Immunol Invest 2021;50:427-44. [PMID: 32522062 DOI: 10.1080/08820139.2020.1775643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Feng Z, Liu W, Jiang HX, Dai H, Gao C, Dong Z, Gao Y, Liu F, Zhang Z, Zhao Q, Zhang L, Liu B. How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy? Front Pharmacol 2020;11:994. [PMID: 32719601 DOI: 10.3389/fphar.2020.00994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Eguchi J, Miyashita K, Fukamachi I, Nakajima K, Murakami M, Kawahara Y, Yamashita T, Ohta Y, Abe K, Nakatsuka A, Mino M, Takase S, Okazaki H, Hegele RA, Ploug M, Hu X, Wada J, Young SG, Beigneux AP. GPIHBP1 autoantibody syndrome during interferon β1a treatment. J Clin Lipidol 2019;13:62-9. [PMID: 30514621 DOI: 10.1016/j.jacl.2018.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Salant DJ. Unmet challenges in membranous nephropathy. Curr Opin Nephrol Hypertens 2019;28:70-6. [PMID: 30451735 DOI: 10.1097/MNH.0000000000000459] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
21 Memar O, Jabbehdari S, Caughlin B, Djalilian AR. Ocular surface involvement in pemphigus vulgaris: An interdisciplinary review. Ocul Surf 2020;18:40-6. [PMID: 31614200 DOI: 10.1016/j.jtos.2019.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Endmayr V, Tunc C, Ergin L, De Rosa A, Weng R, Wagner L, Yu TY, Fichtenbaum A, Perkmann T, Haslacher H, Kozakowski N, Schwaiger C, Ricken G, Hametner S, Klotz S, Dutra LA, Lechner C, de Simoni D, Poppert KN, Müller GJ, Pirker S, Pirker W, Angelovski A, Valach M, Maestri M, Guida M, Ricciardi R, Frommlet F, Sieghart D, Pinter M, Kircher K, Artacker G, Höftberger R, Koneczny I. Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study. Front Immunol 2021;12:785247. [PMID: 35095860 DOI: 10.3389/fimmu.2021.785247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Dalakas MC. IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti-B Cell Therapies. Neurol Neuroimmunol Neuroinflamm 2022;9:e1116. [PMID: 34845096 DOI: 10.1212/NXI.0000000000001116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
24 Vergoossen DLE, Augustinus R, Huijbers MG. MuSK antibodies, lessons learned from poly- and monoclonality. J Autoimmun 2020;112:102488. [PMID: 32505442 DOI: 10.1016/j.jaut.2020.102488] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 van der Veen SJ, van Kuilenburg ABP, Hollak CEM, Kaijen PHP, Voorberg J, Langeveld M. Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment. Mol Genet Metab 2019;126:162-8. [PMID: 30473480 DOI: 10.1016/j.ymgme.2018.11.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
26 Bukiri H, Ruhoy SM, Buckner JH. Sudden Cardiac Death due to Coronary Artery Vasculitis in a Patient with Relapsing Polychondritis. Case Rep Rheumatol 2020;2020:5620471. [PMID: 33282427 DOI: 10.1155/2020/5620471] [Reference Citation Analysis]
27 Treger RS, Fink SL. Beyond Titer: Expanding the Scope of Clinical Autoantibody Testing. The Journal of Applied Laboratory Medicine 2022;7:99-113. [DOI: 10.1093/jalm/jfab123] [Reference Citation Analysis]
28 Satta N, Frias MA, Vuilleumier N, Pagano S. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases? Curr Pharm Des 2019;25:3128-46. [PMID: 31470782 DOI: 10.2174/1381612825666190830164917] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
29 Lateb M, Ouahmi H, Payré C, Brglez V, Zorzi K, Dolla G, Zaidan M, Boyer-Suavet S, Knebelmann B, Crépin T, Courivaud C, Jourde-Chiche N, Esnault V, Lambeau G, Seitz-Polski B. Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation. J Immunol Res 2019;2019:1324804. [PMID: 32083137 DOI: 10.1155/2019/1324804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
30 Watanabe T, Minaga K, Kamata K, Kudo M, Strober W. Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease. Trends Immunol. 2018;39:874-889. [PMID: 30401468 DOI: 10.1016/j.it.2018.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
31 Koneczny I, Herbst R. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. Cells. 2019;8 . [PMID: 31269763 DOI: 10.3390/cells8070671] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
32 Thurman JM, Panzer SE, Le Quintrec M. The role of complement in antibody mediated transplant rejection. Mol Immunol 2019;112:240-6. [PMID: 31195225 DOI: 10.1016/j.molimm.2019.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
33 Koneczny I. Update on IgG4-mediated autoimmune diseases: New insights and new family members. Autoimmun Rev 2020;19:102646. [PMID: 32801046 DOI: 10.1016/j.autrev.2020.102646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
34 Chen Y, Pei Y, Luo J, Huang Z, Yu J, Meng X. Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice. Front Immunol 2020;11:1088. [PMID: 32547566 DOI: 10.3389/fimmu.2020.01088] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
35 Budhram A, Dubey D, Sechi E, Flanagan EP, Yang L, Bhayana V, Mckeon A, Pittock SJ, Mills JR. Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis. Clinical Chemistry 2020;66:1496-509. [DOI: 10.1093/clinchem/hvaa254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
36 Zhao Q, Dai H, Liu X, Jiang H, Liu W, Feng Z, Zhang N, Gao Y, Dong Z, Zhou X, Du J, Zhang N, Rui H, Yuan L, Liu B. Helper T Cells in Idiopathic Membranous Nephropathy. Front Immunol 2021;12:665629. [PMID: 34093559 DOI: 10.3389/fimmu.2021.665629] [Reference Citation Analysis]
37 Ogata H, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Isobe N, Kira JI. Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody. Ann Clin Transl Neurol 2019;6:2304-16. [PMID: 31657126 DOI: 10.1002/acn3.50931] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
38 Minaga K, Watanabe T, Hara A, Kamata K, Omoto S, Nakai A, Otsuka Y, Sekai I, Yoshikawa T, Yamao K, Takenaka M, Chiba Y, Kudo M. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease. Sci Rep 2020;10:14879. [PMID: 32938972 DOI: 10.1038/s41598-020-71848-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
39 Caza TN, Al-Rabadi LF, Beck LH Jr. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Front Immunol 2021;12:800242. [PMID: 34899763 DOI: 10.3389/fimmu.2021.800242] [Reference Citation Analysis]
40 Nissen MS, Blaabjerg M. Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature. Front Neurol 2019;10:1056. [PMID: 31632341 DOI: 10.3389/fneur.2019.01056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
41 Huijbers MG, Vergoossen DL, Fillié-Grijpma YE, van Es IE, Koning MT, Slot LM, Veelken H, Plomp JJ, van der Maarel SM, Verschuuren JJ. MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity. Neurol Neuroimmunol Neuroinflamm 2019;6:e547. [PMID: 30882021 DOI: 10.1212/NXI.0000000000000547] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 11.7] [Reference Citation Analysis]
42 Maslinska M, Dmowska-chalaba J, Jakubaszek M. The Role of IgG4 in Autoimmunity and Rheumatic Diseases. Front Immunol 2022;12:787422. [DOI: 10.3389/fimmu.2021.787422] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Cao M, Koneczny I, Vincent A. Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment. Front Mol Neurosci 2020;13:159. [PMID: 32982689 DOI: 10.3389/fnmol.2020.00159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Sawamura M, Komatsuda A, Kaga H, Saito A, Yasuda T, Wakui H, Joh K, Takahashi N. Membranous nephropathy with solitary polyclonal IgA deposition: A case report and literature review. Clin Nephrol Case Stud 2019;7:60-5. [PMID: 31673485 DOI: 10.5414/CNCS109807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Baudin P, Cousyn L, Navarro V. The LGI1 protein: molecular structure, physiological functions and disruption-related seizures. Cell Mol Life Sci 2021;79:16. [PMID: 34967933 DOI: 10.1007/s00018-021-04088-y] [Reference Citation Analysis]
46 Koneczny I, Yilmaz V, Lazaridis K, Tzartos J, Lenz TL, Tzartos S, Tüzün E, Leypoldt F. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common? Front Immunol 2020;11:605214. [PMID: 33584677 DOI: 10.3389/fimmu.2020.605214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Thurman JM, Yapa R. Complement Therapeutics in Autoimmune Disease. Front Immunol 2019;10:672. [PMID: 31001274 DOI: 10.3389/fimmu.2019.00672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
48 Koneczny I, Tzartos J, Mané-damas M, Yilmaz V, Huijbers MG, Lazaridis K, Höftberger R, Tüzün E, Martinez-martinez P, Tzartos S, Leypoldt F. IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies. Front Immunol 2022;13:834342. [DOI: 10.3389/fimmu.2022.834342] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader‐meunier B, Hachulla E, Hamidou M, Huë S, Charuel J, Fabien N, Viailly P, Allenbach Y, Benveniste O, Cordel N, Boyer O; the OncoMyositis Study Group. The IgG2 Isotype of Anti–Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis. Arthritis Rheumatol 2019;71:1360-70. [DOI: 10.1002/art.40895] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
50 Henson D, Tahhan AS, Nardo D, Quyyumi AA, Venditto VJ. Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events-Brief Report. Arterioscler Thromb Vasc Biol 2019;39:1884-92. [PMID: 31315438 DOI: 10.1161/ATVBAHA.119.312964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 Vergoossen DLE, Plomp JJ, Gstöttner C, Fillié-Grijpma YE, Augustinus R, Verpalen R, Wuhrer M, Parren PWHI, Dominguez-Vega E, van der Maarel SM, Verschuuren JJ, Huijbers MG. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. Proc Natl Acad Sci U S A 2021;118:e2020635118. [PMID: 33753489 DOI: 10.1073/pnas.2020635118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]